Surgical Management of

Sinonasal cancers account for less than 1 % of all malignancies and comprise 3 % of all head and neck malignancies. The most common malignant neo-plasm in the sinuses and nose is squamous cell carcinoma, which accounts for 70 % of these neo-plasms. Most of these arise in the maxillary antrum, and only 10 % to 30 % occur in the nasal cavity or ethmoid sinus. It is well known the surgery is primary treatment for sinonasal malignancies. Adjunctive irradiation and/or chemoradiatioin has resulted in improved locoregional control and increased survival rates. The goal of surgical resection is to remove the can-cer en bloc, with clear margin devoid of neoplasti